Bayever, Eliel,Dhindsa, Navreet,Fitzgerald, Jonathan Basil,Laivins, Peter,Moyo, Victor,Niyikiza, Clet,Kim, Jaeyeon
申请号：
AU2018201942
公开号：
AU2018201942B2
申请日:
2018.03.19
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
#$%^&*AU2018201942B220191205.pdf#####Abstract Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
